Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Evil Rabbit's Profile
Displaying 2551-2600 of 6045 result(s).
CYDY CytoDyn Inc
09/15/2021 11:05:42 PM
You mean like the hospital ship tha (1)
CYDY CytoDyn Inc
09/15/2021 7:47:25 PM
MDV...are you trying to help or obf (3)
CYDY CytoDyn Inc
09/15/2021 7:14:29 PM
It's all fake like the moon landing (5)
CYDY CytoDyn Inc
09/15/2021 4:53:13 PM
You're a note-taking monster and I (3)
CYDY CytoDyn Inc
09/15/2021 2:01:25 PM
Lawman, you contribute nothing to t (18)
CYDY CytoDyn Inc
09/15/2021 1:06:17 PM
...apparently puts me in the looney (5)
CYDY CytoDyn Inc
09/15/2021 1:00:49 PM
The most recent stat I saw was 674, (2)
CYDY CytoDyn Inc
09/15/2021 12:56:44 PM
The interview will available on You (1)
CYDY CytoDyn Inc
09/15/2021 12:05:07 PM
Would 1 in 600 make you feel better (4)
CYDY CytoDyn Inc
09/15/2021 11:36:47 AM
With regard to death toll… it’s (2)
CYDY CytoDyn Inc
09/15/2021 11:26:06 AM
Is there actually someone out there
CYDY CytoDyn Inc
09/15/2021 10:06:34 AM
That’s great to hear. I can’t w
CYDY CytoDyn Inc
09/15/2021 12:41:53 AM
are there any mods that enforce TO (5)
CYDY CytoDyn Inc
09/14/2021 11:47:56 PM
It does have something to do with (2)
CYDY CytoDyn Inc
09/14/2021 10:59:38 PM
The pps declined all summer, then s (14)
CYDY CytoDyn Inc
09/14/2021 9:22:13 PM
I guarantee I've been doing this s (3)
CYDY CytoDyn Inc
09/14/2021 6:09:44 PM
Truthfully, I have very low expecta (2)
CYDY CytoDyn Inc
09/14/2021 5:45:11 PM
I worry folks are hoping for too mu
CYDY CytoDyn Inc
09/14/2021 4:05:25 PM
Revenue biotech is priced on fundam (2)
CYDY CytoDyn Inc
09/14/2021 3:52:22 PM
Current PPS is actually multiples * (6)
CYDY CytoDyn Inc
09/14/2021 3:08:01 PM
Ha. I think you take "priced in" to (3)
CYDY CytoDyn Inc
09/14/2021 2:55:06 PM
Brazil was priced in, huh? Wait unt (1)
CYDY CytoDyn Inc
09/14/2021 1:36:02 PM
Ooh, 7 is good. I knew LL worked fo (1)
CYDY CytoDyn Inc
09/14/2021 11:12:22 AM
Come on, Shopcop, use all 5 posts e (12)
CYDY CytoDyn Inc
09/14/2021 11:11:21 AM
Shorts spinning BS tales based on N (2)
CYDY CytoDyn Inc
09/14/2021 9:07:45 AM
His post doesn’t past the smell t (4)
CYDY CytoDyn Inc
09/13/2021 4:04:16 PM
NP said ANVISA asked for some info (2)
CYDY CytoDyn Inc
09/13/2021 2:40:09 PM
Would be great to see another end o (5)
CYDY CytoDyn Inc
09/13/2021 11:12:56 AM
I can’t recall. Has Leronlimab be
CYDY CytoDyn Inc
09/11/2021 5:29:51 PM
Your last 3 posts (out of 8 total) (11)
CYDY CytoDyn Inc
09/11/2021 11:41:23 AM
Emerging Growth posted this on iHub (3)
CYDY CytoDyn Inc
09/11/2021 12:58:54 AM
I had an exchange with Mark Sumner (24)
CYDY CytoDyn Inc
09/11/2021 12:00:59 AM
That’s a must-read post. Thanks.
CYDY CytoDyn Inc
09/10/2021 5:50:48 PM
Because he thinks the solution is a
CYDY CytoDyn Inc
09/10/2021 5:47:08 PM
I assume bc your first post was pol (2)
CYDY CytoDyn Inc
09/10/2021 5:12:03 PM
Is it me or did all the most active
CYDY CytoDyn Inc
09/10/2021 4:56:58 PM
A dozen posts about pennies. You're (7)
CYDY CytoDyn Inc
09/10/2021 4:22:18 PM
You really believe the video had a (2)
CYDY CytoDyn Inc
09/10/2021 4:03:35 PM
The FDA letter was probably the sol (5)
CYDY CytoDyn Inc
09/10/2021 3:56:00 PM
That was my point in my post showin (4)
CYDY CytoDyn Inc
09/10/2021 3:07:42 PM
Unnecessary. The moment the video d (1)
CYDY CytoDyn Inc
09/10/2021 2:53:20 PM
Don't you just love it... when ever (1)
CYDY CytoDyn Inc
09/10/2021 2:27:58 PM
Every reason to be optimistic in ge (4)
CYDY CytoDyn Inc
09/10/2021 2:26:19 PM
What's with you and the butthurt th (1)
CYDY CytoDyn Inc
09/10/2021 2:24:34 PM
I'm usually the one being berated f (3)
CYDY CytoDyn Inc
09/10/2021 1:58:21 PM
"Readout" of the interim results co (2)
CYDY CytoDyn Inc
09/10/2021 1:45:11 PM
Even if we enroll the interim numbe (2)
CYDY CytoDyn Inc
09/10/2021 1:08:12 PM
It is what it is... however, I thin (10)
CYDY CytoDyn Inc
09/10/2021 12:49:27 PM
we're up 4%!!! That can’t be. Br (6)
CYDY CytoDyn Inc
09/10/2021 12:34:34 PM
Maybe you could have learned somet (7)
Go to page:
  • << First
  • < Previous
  • 51
  • 52
  • Next >

Recent Articles

  • SERES Power Unveils Innovative Range-Extender Technology
  • Chipotle's Exciting Expansion Into Asia Via SPC Partnership
  • Reflecting on Resilience: Insights from Art Ally on 9/11
  • Steven J. Jerina Appointed Vice President at Central Florida Foundation
  • KBR, Inc. Shareholder Rights Investigation: What Investors Need to Know
  • Lyno AI: Transforming Investment Through AI-Driven Trading
  • Satlink and Rivada Join Forces for Cutting-Edge Connectivity Solutions
  • Snap Inc. Investors Must Act Before October Deadline for Class Action
  • Investors Affected by Fly-E Group, Inc. Lawsuit Alerted
  • Bitcoin's Ascent: An Insight into Market Trends and Tokens
  • Understanding the Trends in Automatic Data Processing Shares
  • Analysis of National Fuel Gas's Short Interest Trends
  • Understanding Annaly Capital's Growing Short Interest Dynamics
  • Transforming Leadership: Mike Walsh Joins DKBinnovative as CEO
  • Understanding the Impact of Geopolitical Tensions on ETFs
  • Increasing Blood Donations Key to Helping Sickle Cell Patients
  • Securing $340M Refinancing for 50 & 70 Columbus Project
  • Silverts Strengthens Adaptive Fashion with Strategic Acquisition
  • Opportunity Knocks: Victoria Tower Office Sale Unveiled
  • Lord Cameron Highlights Rare Disease Innovation at Morgan Stanley
  • Seguritech Celebrates 30 Years of Innovation in Security Tech
  • DePauw University Demonstrates Significant Local Economic Influence
  • FG Communities Strengthens Presence with Recent Acquisition
  • Investigation of Quanex Building Products: Key Insights and Updates
  • Investigation Launched for AVITA Medical Investors Amid Concerns
  • Pomerantz Firm Looks Into Geely Automobile Investor Concerns
  • Spectrum Pharmaceuticals Faces Legal Challenges - SPPI Update
  • Celebrating a Century of Community at John C. Campbell Folk School
  • AstraZeneca's Koselugo Approved for Younger Pediatric Patients
  • BioXcel Therapeutics Enhances Agitation Management with BXCL501
  • Breakthrough in Cancer Treatment: PMV Pharmaceuticals Updates
  • Oracle's Record Backlog and AI Growth Propel Stock Surge
  • Avidity Biosciences Achieves Promising Milestones in DMD Trials
  • Thriving Future for Trans-1,2-Dichloroethylene Market Growth
  • CIRO Schedules Hearing for Abid Hossain: Key Details Explained
  • Gartner Inc. Insights: Analyzing Current Stock Performance
  • Understanding Current Trends in Options Trading for Exxon Mobil
  • Landsbankinn hf. Concludes Successful Covered Bond Auction
  • Understanding the Current Trends in META's Options Market
  • Insights Into Circle Internet Group's Recent Trading Trends
  • Muinzer Welcomes New Director of Asset Management for Expansion
  • Biocon Expands Horizons with New U.S. Manufacturing Facility
  • VIVA Foundation to Present Breakthrough Vascular Research in 2025
  • Acadia Healthcare Faces Challenges with Medicaid Payment Cuts
  • Experience The Witcher Through Exclusive Eyewear Designs
  • NYBRA Plastic Surgery Partners with ARSA for Enhanced Care
  • Eraaya Lifespaces Appoints Gagan Sethi as New CEO for Growth
  • Satlink and Rivada: Pioneering Secure Satellite Solutions
  • Austin Company Unveils Advanced Spacecraft Manufacturing Hub
  • DePauw University's Significant Economic Contributions Explored
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site